Benzyl Benzoate

Benzyl Benzoate

SCHEMBL901058

O=C(OCc1ccccc1)c1ccccc1.O=C(OCc1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 1.00
TDP1 Q9NUW8 4/20 1.00
SLC6A2 P23975 1/20 1.00
SLC6A3 Q01959 1/20 1.00
LMNA P02545 4/20 0.81
ALDH1A1 P00352 8/20 0.69
MAPT P10636 2/20 0.69
HPGD P15428 1/20 0.69
MEN1 O00255 1/20 0.64
RAB9A P51151 5/20 0.61
GAA P10253 1/20 0.61
NPC1 O15118 3/20 0.60
MAPK1 P28482 2/20 0.59
HIF1A Q16665 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
SMN1; SMN2 Q16637 2/20 0.58
ESR1 P03372 1/20 0.58
ESR2 Q92731 1/20 0.58
KDM4E B2RXH2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzyl Benzoate SCHEMBL8010992 1.00 KMT2A (1.00) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL3038 1.00 KMT2A (1.00) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL27679311 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL27470495 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL29144647 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL28370886 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL29007153 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL29101943 0.98 KMT2A (0.96) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL27990934 0.96 KMT2A (0.92) KMT2ATDP1SLC6A2SLC6A3LMNA
Benzyl Benzoate SCHEMBL27589165 0.96 TDP1 (0.92) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113453724-A Sulfonylmaleimide-based linkers and corresponding conjugates 皮埃尔法布雷医药公司 2021-09-28 CN disclosed
US-11062794-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
EP-3465198-A1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS Givaudan S.A. (CH) 2019-04-10 EP disclosed
US-20180253534-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-09-06 US disclosed
EP-3365418-A2 PARTICLES FOR MALODOR REDUCTION The Procter and Gamble Company (US) 2018-08-29 EP disclosed
WO-2017207467-A1 METHOD OF RESOLVING ALLERGENS IN PERFUME INGREDIENTS GIVAUDAN SA (CH) 2017-12-07 WO disclosed
EP-3197508-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
EP-3197426-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
EP-3197424-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
EP-3197422-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS The Procter & Gamble Company (US) 2017-08-02 EP disclosed
EP-2070510-A1 Personal cleansing system Takasago International Corporation (JP) 2009-06-17 EP disclosed
EP-1894603-A1 Encapsulation of bulky fragrance molecules Takasago International Corporation (JP) 2008-03-05 EP disclosed
CN-101091797-A Method for taking off endotoxin in primary pure plasmids or proteins, and kit HAIGUI BIOTECH CO LTD (CN) 2007-12-26 CN disclosed
WO-2007038524-A2 COCRYSTALLIZATION METHODS SSCI, INC. (US) 2007-04-05 WO disclosed
EP-1381347-A1 ANTIPERSPIRANT ACTIVES FROM A GLASS FORM AND PRODUCTS MADE THEREWITH Colgate-Palmolive Company (US) 2004-01-21 EP disclosed
EP-1292274-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES Colgate-Palmolive Company (US) 2003-03-19 EP disclosed
WO-2002085321-A1 ANTIPERSPIRANT ACTIVES FROM A GLASS FORM AND PRODUCTS MADE THEREWITH COLGATE-PALMOLIVE COMPANY (US) 2002-10-31 WO disclosed
WO-2001097768-A2 METHOD OF MAKING ENHANCED EFFICACY ANTIPERSPIRANT ACTIVES COLGATE-PALMOLIVE COMPANY (US) 2001-12-27 WO disclosed
US-5955081-A TREATMENT OF SKIN DISORDERS WITH PLANT EXTRACTS Z-92, INC. 1999-09-21 US disclosed
US-5852060-A Antipsoriatic compositions, method of making, and method of using MOADY MARZOOK (US) 1998-12-22 US disclosed